News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Angel Biotechnology Ltd And CellCure A/S Announce GMP Contract For Phase II Clinical Trials


11/30/2006 2:51:05 PM

Angel Biotechnology Holdings plc, (AIM: ABH) the biopharmaceutical contract manufacturer, is pleased to announce a Development and GMP Manufacturing deal with CellCure A/S. Terms of the contract have not been disclosed.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES